- Home
- NHS vs OSUR Comparison
NHS vs OSUR Comparison
Compare NHS & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NHS
- OSUR
- Stock Information
- Founded
- NHS 2003
- OSUR 2000
- Country
- NHS United States
- OSUR United States
- Employees
- NHS N/A
- OSUR N/A
- Industry
- NHS Trusts Except Educational Religious and Charitable
- OSUR Medical/Dental Instruments
- Sector
- NHS Finance
- OSUR Health Care
- Exchange
- NHS Nasdaq
- OSUR Nasdaq
- Market Cap
- NHS 232.6M
- OSUR 229.7M
- IPO Year
- NHS N/A
- OSUR 1986
- Fundamental
- Price
- NHS $7.50
- OSUR $3.34
- Analyst Decision
- NHS
- OSUR Hold
- Analyst Count
- NHS 0
- OSUR 1
- Target Price
- NHS N/A
- OSUR $3.00
- AVG Volume (30 Days)
- NHS 111.8K
- OSUR 618.4K
- Earning Date
- NHS 01-01-0001
- OSUR 08-05-2025
- Dividend Yield
- NHS 13.44%
- OSUR N/A
- EPS Growth
- NHS N/A
- OSUR N/A
- EPS
- NHS N/A
- OSUR N/A
- Revenue
- NHS N/A
- OSUR $138,533,000.00
- Revenue This Year
- NHS N/A
- OSUR N/A
- Revenue Next Year
- NHS N/A
- OSUR $5.35
- P/E Ratio
- NHS N/A
- OSUR N/A
- Revenue Growth
- NHS N/A
- OSUR N/A
- 52 Week Low
- NHS $6.95
- OSUR $2.36
- 52 Week High
- NHS $9.17
- OSUR $4.61
- Technical
- Relative Strength Index (RSI)
- NHS 60.17
- OSUR 62.86
- Support Level
- NHS $7.34
- OSUR $2.76
- Resistance Level
- NHS $7.47
- OSUR $2.93
- Average True Range (ATR)
- NHS 0.04
- OSUR 0.15
- MACD
- NHS 0.01
- OSUR 0.07
- Stochastic Oscillator
- NHS 100.00
- OSUR 77.27
About NHS Neuberger Berman High Yield Strategies Fund
Neuberger Berman High Yield Strategies Fund Inc is a diversified, closed-end management investment company. The company invests in high yield debt securities market. The Fund uses leverage to pursue its investment objective. The Fund may invest in a variety of direct debt instruments, including bank loans, notes and other interests in amounts owed to financial institutions by borrowers, such as companies and governments. Corporate loans in which the Fund may invest will consist of direct obligations of borrowers. The Fund may invest in corporate loans at origination as a co-lender or may acquire loans in the secondary market by purchasing participations in, assignments of or novations of corporate loans.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.